Based on the SMILES C=C(C)O[C@@]12CO[C@@H]1C[C@@H]1C[C@@]13C(=O)[C@H](OC(C)=O)C1=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@H](OC(=O)c4ccccc4)[C@H]23)C1(C)C, the molecule has a drug half life time in humans after IV administration of 20.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
[(1S,2R,3R,4S,7R,9S,11R,13R,16S)-13-acetyloxy-1-hydroxy-16-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-15,18,18-trimethyl-12-oxo-4-prop-1-en-2-yloxy-6-oxapentacyclo[12.3.1.03,11.04,7.09,11]octadec-14-en-2-yl] benzoate